GENE ONLINE|News &
Opinion
Blog

Cardiovascular
News Flash Merck
Merck Enters $2 Billion Agreement to Develop Lipoprotein(a) Inhibitor for Atherosclerosis Treatment
2025-03-26
Ranking & Reports Johnson & JohnsonQ2 Report
J&J’s Q2 Increase: Cardiovascular Gains and Strategic Moves Amid Vaccine Decline
2024-08-06
China Takeda Pharmaceutical
Shanghai’s Hasten Seals $322 Million Acquisition of Takeda Drugs
2022-04-06
M&A Best of 2021
GeneOnline’s Top 10 M&As of 2021
2022-01-11
China IPO
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
LATEST
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top